AbbVie has selected North Carolina as the site for a new $1.4 billion manufacturing campus that will integrate artificial intelligence with advanced production and laboratory technologies to support its immunology, neuroscience, and oncology medicine lines. No timeline for completion was announced. The investment reflects both the scale of AbbVie’s pipeline ambitions and a broader pharmaceutical industry trend toward AI-assisted manufacturing—applying machine learning to process optimization, quality control, and yield prediction in ways that reduce variability and regulatory risk.

The American Foundation for Suicide Prevention (AFSP) and The Jed Foundation (JED) have announced their intent to merge as equals, a combination that would create the largest nonprofit organization in the United States dedicated exclusively to suicide prevention across all life stages. The merged organization aims to establish a coordinated national prevention strategy spanning youth through adulthood. The two organizations have historically occupied complementary but distinct lanes: JED has focused primarily on youth and young adult mental health, particularly on college campuses, while AFSP has operated across a broader demographic range with a strong emphasis on research funding and survivor support.

Blue Energy has raised $380 million to build what it describes as the world’s first project-financeable nuclear power plant, using a prefabricated design compatible with leading reactor technologies and targeting a 48-month construction timeline. CEO Jake Jurewicz characterized the effort as building a nuclear product designed to scale. The phrase “project-financeable” is doing significant work in this announcement. Conventional nuclear construction has been chronically unable to attract project finance—debt secured against the cash flows of the plant itself rather than the balance sheet of a large utility—because cost overruns, timeline uncertainty, and regulatory complexity make the risk profile unacceptable to lenders.

Burger King is launching a limited-time menu tied to the upcoming Star Wars: The Mandalorian and Grogu film, featuring a themed Whopper, sides, shake, and collectible cups available nationwide starting May the Fourth. A Mandalorian and Grogu King Jr. Meal for children arrives at participating locations on April 28. Branded fast food promotions tied to major film releases have been a durable marketing format for decades, and Star Wars properties have historically produced among the most commercially successful.

Cognizant and OpenAI have announced a partnership to deploy AI-powered software engineering, modernization, and security compliance capabilities—built on OpenAI’s Codex—to enterprise clients across industries. The collaboration targets complexity reduction, faster delivery cycles, and the governance structures required for enterprise-grade adoption. The partnership is a textbook play for both parties. For OpenAI, Cognizant’s client base of large enterprises across financial services, healthcare, manufacturing, and retail provides distribution at a scale that direct sales cannot easily replicate—and each enterprise deployment generates the usage data and feedback loops that sharpen the models.

Eli Lilly has announced a deal to acquire Kelonia Therapeutics, gaining access to KLN-1010, a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 trials for relapsed or refractory multiple myeloma, with data recently featured at the 2025 ASH Annual Meeting plenary session. The acquisition also brings Kelonia’s in vivo gene delivery and integration platform, which Lilly views as broadly applicable across its genetic medicine programs. The distinction between in vivo and ex vivo CAR-T is significant.

Frontier Airlines has launched its 2026 GoWild Summer Pass at an introductory price of $199, offering more than five months of unlimited flights through a limited-time early purchase window before the price increases. The pass covers Frontier’s network including Florida, the Rocky Mountains, Las Vegas, and other destinations. The GoWild pass is a product that works as a revenue tool and a marketing tool simultaneously. At $199, Frontier is selling inventory it might otherwise leave empty—ultra-low-cost carriers operate on unit economics where load factor optimization is paramount, and a pass holder filling a seat that would otherwise fly empty costs the airline very little in marginal terms.

Honeywell has agreed to sell its Productivity Solutions and Services division to Brady Corporation in a $1.4 billion deal expected to close in the second half of 2026, subject to regulatory approval. The divestiture is part of Honeywell’s ongoing portfolio simplification and runs parallel to its planned Aerospace spin-off, currently on track for Q3 2026. Honeywell’s transformation over the past two years reads as a deliberate narrowing: identifying the highest-margin, highest-growth segments and shedding the rest.

Jersey Mike’s has confidentially submitted a draft registration statement to the SEC for a proposed initial public offering, with no share count or price range yet disclosed. The offering remains subject to market conditions and completion of the SEC review process. The confidential filing route—established under the JOBS Act—allows companies to test regulatory reception and refine their S-1 before public scrutiny begins, giving management more flexibility to adjust timing if market conditions shift.

Northwest Biotherapeutics has established a dedicated leukapheresis clinic at The London Welbeck Hospital, designed to process up to four patients per day with capacity for extended hours and weekend operations as demand scales. The facility is intended to support the company’s cell therapy pipeline by bringing the collection process in-house. Leukapheresis—the extraction of white blood cells from a patient’s blood for use in manufacturing personalized immunotherapies—has long been a logistical bottleneck in the cell therapy supply chain.